-Advertisement-
-Advertisement-
Cataract/Anterior Segment
Lensar announces FDA clearance for ALLY Adaptive Cataract Treatment System
Lensar announced it has received U.S. Food and Drug Administration 510(k) clearance for its next-generation ALLY Adaptive Cataract Treatment System, according to a company press release. This is the first FDA-cleared system enabling surgeons to complete femtosecond-laser-assisted cataract (FLACS) procedure surgery in a single, sterile environment. A targeted initial launch...
Read More By rd360stg
-Advertisement-
-Advertisement-
-Advertisement-
By rd360stg
By rd360stg
-Advertisement-
-Advertisement-
-Advertisement-
By rd360stg
By rd360stg
-Advertisement-
-Advertisement-
Videos
-Advertisement-
-Advertisement-

Stay Connected! Join Our Newsletter
Contact
Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809
+908-505-8899
[email protected]
QUICK LINKS
© 2022 IHM. Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights Reserved